Physician profile
Denay M May
NPI 1841528791
$1,776.24
in general payments reported to CMS, 2019-2025
19 companies · $245 in 2025
The $245 reported for 2025 was more than what 85% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $527 · 2022: $309 · 2023: $579 · 2024: $116 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $559 · Education: $381.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $559.34 |
| Education | $380.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $550.05 | 2023-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $393.26 | 2021 | |
| Organon LLC | $187.86 | 2021-2025 | Nexplanon |
| Sage Therapeutics, LLC | $105.86 | 2024-2025 | Zurzuvae |
| Channel Medsystems, INC. | $74.98 | 2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $65.07 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $64.36 | 2021-2023 | |
| Abbvie INC. | $53.41 | 2021-2022 | |
| Exeltis, USA INC. | $42.43 | 2021-2025 | Slynd |
| Pfizer INC. | $41.61 | 2021-2023 | |
| Convatec INC. | $31.22 | 2022 | |
| Amgen INC. | $29.93 | 2022 | |
| Therapeuticsmd, INC. | $28.47 | 2022 | |
| Supernus Pharmaceuticals, INC. | $21.96 | 2025 | Qelbree |
| Baxter Healthcare | $19.14 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $18.45 | 2022 | |
| Hologic Sales and Service, LLC | $16.53 | 2022 | |
| Myovant Sciences INC. | $16.35 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $15.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Denay May listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.